Clinical Trial Update: Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 trial evaluating vorinostat, isotretinoin, and temozolomide in adults with recurrent glioblastoma and anaplastic glioma has posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma
• Glioblastoma

Drugs mentioned

• Accutane (isotretinoin)
• Temodar (Temozolomide)
• Vorinostat (vorinostat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Glioblastoma Multiforme, Anaplastic Glioma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-08-22